Skip to main content

MoneyWorks4Me

Aurobindo Pharma submits press release

14 Apr 2025 Evaluate

Aurobindo Pharma has submitted a press release on receipt of final ANDA approval for RivaroxavanTablets USP.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..